Sutro Biopharma Financial Overview
Sutro Biopharma's market cap is currently $77.78M. The company's EPS TTM is $-6.7; its P/E ratio is -0.34; Sutro Biopharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-8.16. See an overview of income statement, balance sheet, and cash flow financials.
